| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)
|
Blood
|
1997
|
2.40
|
|
2
|
Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.
|
Leukemia
|
2004
|
1.58
|
|
3
|
Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples.
|
Leukemia
|
2006
|
1.53
|
|
4
|
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.
|
Leukemia
|
2005
|
1.50
|
|
5
|
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.
|
Br J Cancer
|
2005
|
1.41
|
|
6
|
Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): single-agent therapeutic window study in relapsed AML.
|
Pediatr Blood Cancer
|
2006
|
1.39
|
|
7
|
Pediatric acute myeloid leukemia: international progress and future directions.
|
Leukemia
|
2005
|
1.37
|
|
8
|
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.
|
Blood
|
1999
|
1.20
|
|
9
|
Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials.
|
Leukemia
|
2010
|
1.20
|
|
10
|
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML.
|
Leukemia
|
2008
|
1.18
|
|
11
|
Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
|
Klin Padiatr
|
2005
|
1.15
|
|
12
|
Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.
|
Leukemia
|
2005
|
1.14
|
|
13
|
Phenotypic and genotypic heterogeneity in infant acute leukemia. II. Acute nonlymphoblastic leukemia.
|
Leukemia
|
1989
|
1.10
|
|
14
|
EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.
|
Leukemia
|
2010
|
1.07
|
|
15
|
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groups.
|
Leukemia
|
2011
|
1.07
|
|
16
|
Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children.
|
Ann Hematol
|
2001
|
1.06
|
|
17
|
Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia.
|
J Clin Oncol
|
2004
|
1.02
|
|
18
|
Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model.
|
Leukemia
|
2011
|
1.01
|
|
19
|
Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78.
|
Blood
|
1985
|
0.99
|
|
20
|
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.
|
Br J Cancer
|
2003
|
0.98
|
|
21
|
Isolated myelosarcoma in children--update and review.
|
Leuk Lymphoma
|
2002
|
0.94
|
|
22
|
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
|
J Clin Oncol
|
1997
|
0.94
|
|
23
|
Different types of NPM1 mutations in children and adults: evidence for an effect of patient age on the prevalence of the TCTG-tandem duplication in NPM1-exon 12.
|
Leukemia
|
2006
|
0.93
|
|
24
|
Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia.
|
Leukemia
|
2005
|
0.93
|
|
25
|
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.
|
Blood
|
2000
|
0.92
|
|
26
|
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
|
Blood
|
1998
|
0.92
|
|
27
|
Primary myelosarcomas are associated with a high rate of relapse: report on 34 children from the acute myeloid leukaemia-Berlin-Frankfurt-Münster studies.
|
Br J Haematol
|
2000
|
0.92
|
|
28
|
Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS).
|
Leukemia
|
1999
|
0.90
|
|
29
|
Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
|
Leuk Lymphoma
|
1999
|
0.90
|
|
30
|
Immunocytochemical detection of deoxycytidine kinase in haematological malignancies and solid tumours.
|
J Clin Pathol
|
2005
|
0.89
|
|
31
|
Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome.
|
Leukemia
|
2007
|
0.87
|
|
32
|
Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia.
|
Leukemia
|
1998
|
0.87
|
|
33
|
High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome.
|
Leukemia
|
2010
|
0.86
|
|
34
|
Allo-SCT using BU, CY and melphalan for children with AML in second CR.
|
Bone Marrow Transplant
|
2012
|
0.85
|
|
35
|
Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
|
Leukemia
|
2000
|
0.85
|
|
36
|
Childhood leukemia: cooperative Berlin-Frankfurt-Münster trials in the Federal Republic of Germany.
|
J Cancer Res Clin Oncol
|
1990
|
0.82
|
|
37
|
[Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
|
Klin Padiatr
|
2002
|
0.82
|
|
38
|
Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria.
|
Pediatr Blood Cancer
|
2013
|
0.82
|
|
39
|
Differences in the prevalence of PTPN11 mutations in FAB M5 paediatric acute myeloid leukaemia.
|
Br J Haematol
|
2005
|
0.81
|
|
40
|
Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity.
|
Br J Haematol
|
2000
|
0.81
|
|
41
|
[GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
|
Klin Padiatr
|
2012
|
0.81
|
|
42
|
In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.
|
Leukemia
|
1995
|
0.80
|
|
43
|
Potentiation of in vitro ara-C cytotoxicity by ribonucleotide reductase inhibitors, cyclin-dependent kinase modulators and the DNA repair inhibitor aphidicolin in paediatric acute myeloid leukaemia.
|
Br J Haematol
|
2005
|
0.80
|
|
44
|
Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
|
Haematologica
|
2001
|
0.79
|
|
45
|
A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia.
|
Eur J Cancer
|
2001
|
0.79
|
|
46
|
Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study.
|
Klin Padiatr
|
1999
|
0.79
|
|
47
|
Gemtuzumab ozogamicin (Mylotarg) in children with refractory or relapsed acute myeloid leukemia.
|
Onkologie
|
2004
|
0.79
|
|
48
|
Role and perspectives of BMT in AML: the BFM experience.
|
Bone Marrow Transplant
|
1991
|
0.78
|
|
49
|
Large interindividual differences in cellular sensitivity to calicheamicin may influence gemtuzumab ozogamicin response in acute myeloid leukemia.
|
Leukemia
|
2008
|
0.78
|
|
50
|
Treatment of acute myelogenous leukemia in children.
|
Med Oncol Tumor Pharmacother
|
1985
|
0.78
|
|
51
|
MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4/M5 acute myeloid leukemia.
|
Leukemia
|
2006
|
0.78
|
|
52
|
Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia.
|
Br J Haematol
|
1999
|
0.78
|
|
53
|
Incidence and clinical implications of acute hybrid leukemia in childhood.
|
Haematol Blood Transfus
|
1990
|
0.78
|
|
54
|
Intensive chemotherapy versus bone marrow transplantation in pediatric acute myeloid leukemia: a matter of controversies.
|
Blood
|
2001
|
0.77
|
|
55
|
The state of research into children with cancer across Europe: new policies for a new decade.
|
Ecancermedicalscience
|
2011
|
0.77
|
|
56
|
Immunocytochemical detection of deoxycytidine kinase in pediatric malignancies in relation to in vitro cytarabine sensitivity.
|
Nucleosides Nucleotides Nucleic Acids
|
2004
|
0.76
|
|
57
|
Circumvention of methotrexate resistance in childhood leukemia subtypes by rationally designed antifolates.
|
Blood
|
1999
|
0.76
|
|
58
|
Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-Group.
|
Leukemia
|
1992
|
0.76
|
|
59
|
Bone marrow transplantation in comparison with conventional therapy in children with adult type chronic myelogenous leukemia.
|
Bone Marrow Transplant
|
1990
|
0.76
|
|
60
|
Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
|
Med Pediatr Oncol
|
1996
|
0.76
|
|
61
|
[Genetic prognostic factors in childhood acute myeloid leukemia].
|
Klin Padiatr
|
2012
|
0.75
|
|
62
|
Bone-marrow transplantation.
|
Lancet
|
1995
|
0.75
|
|
63
|
Acute myelogenous leukaemia in children under 2 years--experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study Group.
|
Br J Cancer Suppl
|
1992
|
0.75
|
|
64
|
Computer-aided documentation and therapy planning in pediatric oncology.
|
Stud Health Technol Inform
|
1998
|
0.75
|
|
65
|
[High dosage ARA-C in combination with mitoxantrone in therapy of acute myeloid leukemia in childhood. Initial results of the AML BFM-85 recurrence study].
|
Onkologie
|
1987
|
0.75
|
|
66
|
[Primary isolated myeolosarcoma in childhood].
|
Klin Padiatr
|
1999
|
0.75
|
|
67
|
[Risk groups in acute, non-lymphatic leukemia in childhood. Analysis of the results of the cooperative therapeutic studies AML-BFM 78 and 83].
|
Onkologie
|
1986
|
0.75
|
|
68
|
The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis.
|
Haematol Blood Transfus
|
1987
|
0.75
|
|
69
|
[Myelodysplastic syndrome: a review].
|
Klin Padiatr
|
1987
|
0.75
|
|
70
|
[Kind-Philipp Symposium in honor to the trustor Dr.-Ing. Walter Reiners and Kind-Philipp Award 2008].
|
Klin Padiatr
|
2009
|
0.75
|
|
71
|
[Acute myelogenous leukemia in children: results of the cooperative BFM-78 therapy study after 3 3/4 years].
|
Klin Padiatr
|
1983
|
0.75
|
|
72
|
[Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols].
|
Gematol Transfuziol
|
1991
|
0.75
|
|
73
|
Effective remission induction in children with recurrent acute myeloid leukemia by mAMSA, Ara-C, and VP 16.
|
Haematol Blood Transfus
|
1987
|
0.75
|
|
74
|
[Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83].
|
Klin Padiatr
|
1989
|
0.75
|
|
75
|
[Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood: a special risk group?].
|
Klin Padiatr
|
1983
|
0.75
|
|
76
|
Surface marker analysis by monoclonal antibodies: a valuable technique in childhood acute myeloid leukemia.
|
Haematol Blood Transfus
|
1987
|
0.75
|
|
77
|
[Milestones of health policy and rare diseases].
|
Klin Padiatr
|
2010
|
0.75
|
|
78
|
[Current results of cooperative AML therapy studies in children: BFM-78 and 83].
|
Klin Padiatr
|
1986
|
0.75
|
|
79
|
Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93.
|
Eur J Clin Microbiol Infect Dis
|
2007
|
0.75
|
|
80
|
[Myelodysplastic diseases in childhood].
|
Klin Padiatr
|
1992
|
0.75
|
|
81
|
[Biclonal leukemia O-ALL/AMoL) with 11;19 translocation and trisomy X in an 8-month-old girl].
|
Klin Padiatr
|
1986
|
0.75
|
|
82
|
[Adult form of chronic myelogenous leukemia in childhood--a retrospective analysis of 20 patients].
|
Klin Padiatr
|
1985
|
0.75
|
|
83
|
[Assessment of staffing and infrastructures of paediatric oncology and haematology centres in Germany].
|
Klin Padiatr
|
2007
|
0.75
|
|
84
|
[Acute myelogenous leukemia in children under 2 years of age: studies and treatment results in 23 children in the AML therapy study BFM-78].
|
Klin Padiatr
|
1984
|
0.75
|
|
85
|
[DNA aneuploidy in children with acute leukemia: I. Incidence and clinical significance within the scope of the BFM studies].
|
Klin Padiatr
|
1985
|
0.75
|
|
86
|
Improved treatment results in childhood acute myelogenous leukemia: an update of the German cooperative study AML-BFM-78.
|
Haematol Blood Transfus
|
1985
|
0.75
|
|
87
|
[Treatment of relapse in acute lymphoblastic leukaemia of childhood (author's transl)].
|
Dtsch Med Wochenschr
|
1980
|
0.75
|
|
88
|
[20 years of German-Russian cooperation in pediatric hematology and oncology].
|
Klin Padiatr
|
2011
|
0.75
|
|
89
|
[Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
|
Klin Padiatr
|
1992
|
0.75
|
|
90
|
Improved results in treatment of acute myelogenous leukemia in children--report of the German cooperative AML study BFM-78.
|
Haematol Blood Transfus
|
1983
|
0.75
|
|
91
|
Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML.
|
Leuk Lymphoma
|
1995
|
0.75
|
|
92
|
[In Process Citation].
|
Internist (Berl)
|
1999
|
0.75
|
|
93
|
[Acute leukemia in a 13-year old boy with a synchronous occurrence of lympho- and monoblasts (author's transl)].
|
Klin Padiatr
|
1981
|
0.75
|
|
94
|
Requirements and design aspects of a data model for a data dictionary in paediatric oncology.
|
Stud Health Technol Inform
|
2000
|
0.75
|
|
95
|
Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-BFM-78 and -83.
|
Med Pediatr Oncol
|
1989
|
0.75
|
|
96
|
Prognostic meaning of chromosome aberrations in acute lymphocytic leukemia and acute nonlymphocytic leukemia patients of the BFM Study Group.
|
Haematol Blood Transfus
|
1987
|
0.75
|
|
97
|
Therapy of childhood acute myelogenous leukemias.
|
Ann Hematol
|
1996
|
0.75
|
|
98
|
3 x 14 mg/m2 idarubicin during induction: results of a pilot study in children with AML.
|
Leukemia
|
2000
|
0.75
|
|
99
|
Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83.
|
Haematol Blood Transfus
|
1990
|
0.75
|
|
100
|
[Antiinfectious prophylaxis in pediatric oncology. Work group "Quality Assurance" of Society for Pediatric Oncology and Hematology (GPOH)].
|
Klin Padiatr
|
1999
|
0.75
|
|
101
|
[Measures of quality assurance for in-patient pediatric oncology units].
|
Klin Padiatr
|
2006
|
0.75
|
|
102
|
[Computer-assisted documentation and therapy planning in pediatric oncology--introduction of a nationwide solution].
|
Klin Padiatr
|
1999
|
0.75
|
|
103
|
[Expert network for pediatric oncology and hematology].
|
Klin Padiatr
|
1999
|
0.75
|
|
104
|
[Adolescents with cancer - administrative, clinical and scientific implications].
|
Klin Padiatr
|
2011
|
0.75
|
|
105
|
[Results of the Competence Net Pediatric Oncology and Haematology--a view back].
|
Klin Padiatr
|
2010
|
0.75
|
|
106
|
12q13, a new recurrent breakpoint in acute non-lymphoblastic leukemia.
|
Cancer Genet Cytogenet
|
1995
|
0.75
|
|
107
|
[Cancer in the children of survivors of acute leukemia or non-Hodgkin's lymphomas in childhood].
|
Strahlenther Onkol
|
1996
|
0.75
|
|
108
|
The problem of early death in childhood AML.
|
Haematol Blood Transfus
|
1987
|
0.75
|
|
109
|
[Differentiation of acute leukemias].
|
Dtsch Med Wochenschr
|
1981
|
0.75
|
|
110
|
[Guidelines for diagnosis and therapy in in pediatric oncology and hematology].
|
Klin Padiatr
|
1996
|
0.75
|
|
111
|
[Neuropsychological sequelae in children with AML treated with or without prophylactic CNS-irradiation].
|
Klin Padiatr
|
2002
|
0.75
|
|
112
|
[Treatment of chronic myeloid leukemia in children and adolescents--concept of the multicenter pilot study CML-ped].
|
Klin Padiatr
|
1996
|
0.75
|
|
113
|
Acute myelogenous leukemia: current status of therapy in children.
|
Recent Results Cancer Res
|
1984
|
0.75
|
|
114
|
[Establishment of a uniform common data set for pediatric oncology. Applied Informatics Study Group of the GPOH (Society of Pediatric Oncology and Hematology)].
|
Klin Padiatr
|
1994
|
0.75
|
|
115
|
[Prognosis, treatment completion, and complications in nonresponders in the study AML-BFM87].
|
Klin Padiatr
|
1999
|
0.75
|
|
116
|
[Standardizing terminology in pediatric oncology--the basic data set].
|
Klin Padiatr
|
2002
|
0.75
|
|
117
|
Karyotypes in acute childhood leukemias may lose prognostic significance with more intensive and specific chemotherapy.
|
Cancer Genet Cytogenet
|
1991
|
0.75
|
|
118
|
[Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study].
|
Klin Padiatr
|
2002
|
0.75
|